Search results
Results From The WOW.Com Content Network
For full-year 2024, Gilead said it still expects product sales of $27.1 billion to $27.5 billion, but raised its adjusted profit estimate to $3.60 to $3.90 a share from a previous $3.45 to $3.85 a ...
Gilead Sciences. Gilead Sciences, Inc. ( / ˈɡɪliəd /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences (NASDAQ: GILD) Q2 2024 Earnings Call Aug 08, 2024, 4:30 p.m. ET. ... Just after market closed today, we issued a press release with earnings results for the second quarter of 2024 ...
(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill ...
Gilead stated they were donating 1.5 million vials for emergency use [83] and estimated, as of April 2020, they had enough remdesivir for 140,000 treatment courses and expect to have 500,000 courses by October 2020, and one million courses by the end of 2020.
Elvitegravir ( EVG) is an integrase inhibitor used to treat HIV infection. It was developed [1] by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. [2] [3] [4] The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012, for use in adult patients starting HIV treatment for ...
Gilead Sciences (GILD) has revealed that its remdesivir Covid-19 treatment will be available to patients early this week. Remdesivir, a direct acting antiviral drug that inhibits viral RNA ...
Gilead. (novel) Gilead is a novel written by Marilynne Robinson published in 2004. It won the 2005 Pulitzer Prize for Fiction and the National Book Critics Circle Award. It is Robinson's second novel, following Housekeeping (1980). Gilead is an epistolary novel, as the entire narrative is a single, continuing, albeit episodic, document, written ...